2nd Quarter - Amendment

SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE for SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE

Firm
Client
Income
—
Expenses
$260,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 20, 2011 $260,000 Replaced
2nd Quarter - Amendment (this page) Sep 30, 2011 $260,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions and provisions on breast health education and appointments to advisory boards. H.R. 1, Full-Year Continuing Appropriations Act, 2011, primarily matters related to appropriations for cancer research and cancer control programs. Implementation of Public Law No. 112-8, Further Additional Continuing Appropriations Amendments, 2011, primarily matters related to appropriations for cancer research and cancer control programs. H.R. 466 / S. 384, Breast Cancer Research Stamp Reauthorization Act. House Res 234 and Senate Res 144, Congressional Resolution for continued funding for the National Breast Cancer and Cervical Cancer Early Detection Program.

LobbyistCovered position, as disclosed
KAREN HANDEL New Special Asst.& D.Chief of Staff to Marilyn Quayle
MATTHEW MOORE —

Contacted: SENATE; Labor, Dept of (DOL); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: S. 384 (112th), H.R. 1 (112th), H.R. 466 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.